Avenue Therapeutics Inc. held its annual meeting of stockholders on December 30, 2025. Shareholders approved the election of six directors and ratified the appointment of KPMG LLP as the company's independent registered public accounting firm for the year ending December 31, 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avenue Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-125420), on December 31, 2025, and is solely responsible for the information contained therein.
Comments